Sky Medical Technology announces the availability of its geko™ device on the Government of India’s (GeM) electronic marketplace portal


Launched in August 2016, the GeM Portal is an online marketplace platform to facilitate the procurement of goods and services by various government departments and agencies. It aims to improve the transparency, efficiency and speed of public procurement of goods and services.

The portable, clinically proven geko™ device – now listed on GeM – is a small, battery-powered disposable neuromuscular electrical stimulation therapy that is applied non-invasively to the skin over the common peroneal nerve on the side of the knee. Small electrical pulses gently stimulate the nerve, once per second, activating muscle pumps in the calf and foot, which leads to increased blood flow in the deep veins1 of the calf, at a pace equal to 60% of continuous walking2 without a patient having to move. Increased blood flow prevents venous thromboembolism3 (VTE – blood clots), reduces postoperative and traumatic swelling4.5 and promotes the healing of wounds (leg ulcers)6.

On the other side India, the incidence of VTE is comparable to that of Western countries. The risk is particularly high in hospitalized patients, in the majority of whom VTE is clinically silent and one of the most common causes of unplanned readmission and preventable Edema, the medical term for swelling, is also a silent burden with few tools to treat the complication, which can delay surgical fixation, prevent wound closure, decrease muscle strength and rehabilitation of stalls.8.9 However, perhaps the greatest burden, considered a silent epidemic, is the burden of chronic wounds. It is difficult to correctly assess the extent of the suffering caused by leg ulcers in a country of more than 1.2 billion inhabitants. One study, however, estimated the prevalence at 4.5 per 1000 in the populationten.

“We are delighted that government hospitals around the world India can now benefit from a streamlined supply of geko™ devices through GeM, to address these important medical challenges,” said Bernard Ross, Founder and CEO of Sky. “GeM’s listing marks the start of a very exciting journey for Sky. The online platform is a dynamic marketplace, offering transparency, efficiency and speed. It is comforting to know that thousands of patients who visit public hospitals can now benefit from the prescribed use of the geko™ device for better clinical outcomes and recovery.

About Sky Medical Technology Ltd

Sky Medical Technology, the parent company of Firstkind Ltd, is a UK-based medical device company. Through its innovative neuromuscular electrical stimulation mechanism, Sky has developed a revolutionary, non-invasive technology platform, OnPulse™, integrated into its industry-leading brand, the geko™ device. Sky’s products are suitable for different areas of medical application, sold through strategic partnerships or distributors in each area of ​​clinical application. Clinical areas of interest include preventing life-threatening blood clots, complications related to swelling before and after general and orthopedic surgery, and vascular conditions related to wound healing (leg ulcers). The goal of each pathway is to partner with healthcare professionals for better patient outcomes and better patient care while saving healthcare system resources.

Media contact

Sue Davenport
[email protected]
Sky Medical Technology Ltd
falcon house
Peregrine Business Park
Gum Road
High Wycombe
HP13 7DL


  1. A Nicolaides, Mrs. Griffin. Measurement of blood flow in the deep veins of the lower limb using the geko™ neuromuscular electrostimulation device. Journal of International Angiology August 2016-04.
  2. Tucker A, et al. Increase in venous, arterial and microvascular vascularization of the leg by isometric neuromuscular stimulation via the peroneal nerve. The International journal of angiology: official publication of the International College of Angiology, Inc. 2010 Spring;19(1):e31-7.
  3. Natarajan I, et al. The use of the geko™ device (a neuromuscular electrostimulation device) and the resulting activation of foot and calf muscle pumps for the prevention of venous veins. thromboembolism in patients with acute stroke. North Midlands NHS Trust University Hospital. Attach. Posted on geko™ device.
  4. Mahmood et al, Neuromuscular Electrical Stimulation Device Reduces Preoperative Edema and Accelerates Theater Readiness in Patients Requiring Open Reduction Internal Fixation for Acute Ankle Fracture, Foot and Ankle Journal, Published in online, March 2020.
  5. Wainwright TW et al. A randomized controlled feasibility trial to assess the efficacy of a new neuromuscular electrical stimulation device in preventing edema formation after total hip arthroplasty. Heliyon July 18, 2018 – Volume 4, Number 7.
  6. Jones NI & Harding KG. Neuromuscular electrostimulation on wounds of the lower limbs. British Journal of Nursing. Vol 27, No 20. Published online: November 12, 2018.
  7. Agarwal S. et al. Venous thromboembolism: a problem in the Indian/Asian population? Indian Journal of Urology: IJU: Journal of the Urological Society of India, 2009 Jan 1, 25(1):11-16 DOI: 10.4103/0970-1591.45531 PMID: 19468423 PMCID: PMC2684304.
  8. Kluga K, et al. Improving the management of orthopedic-related postoperative edema in a rehabilitation nursing setting. Rehabilitation nurses. May/June 2019;44(3):151-160. doi: 10.1097/rnj.0000000000000104.
  9. US Department of Veterans Affairs VA website:
  10. Vijay Langer. Leg Ulcers: An Indian Perspective. Online Journal of Indian Dermatology. 2014 October-December; 5(4): 535–536. doi: 10.4103/2229-5178.142559. PMCID: PMC4228669. PMID: 25396157.

Photo –
Photo –
Logo –
Logo –

SOURCESky Medical Technology Ltd.

Source link


Comments are closed.